[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population].
- DOI
- 10.3760/cma.j.cn121090-20250626-00300
- Published
- 2025-12-01
- Container
- Zhonghua Xue Ye Xue Za Zhi
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3760/cma.j.cn121090-20250626-00300,
title = {[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population].},
author = {Xuan L and Huang H and Xu LP and Fu YW and Chen F and Wang Y and Wang SQ and Dong L and Wu JY and Wu DP.},
year = {2025},
journal = {Zhonghua Xue Ye Xue Za Zhi},
doi = {10.3760/cma.j.cn121090-20250626-00300},
url = {https://doi.org/10.3760/cma.j.cn121090-20250626-00300}
}RIS
TY - JOUR TI - [Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. AU - Xuan L AU - Huang H AU - Xu LP AU - Fu YW AU - Chen F AU - Wang Y AU - Wang SQ AU - Dong L AU - Wu JY AU - Wu DP. PY - 2025 JO - Zhonghua Xue Ye Xue Za Zhi DO - 10.3760/cma.j.cn121090-20250626-00300 UR - https://doi.org/10.3760/cma.j.cn121090-20250626-00300 ER -
APA
L, X., H, H., LP, X., YW, F., F, C., Y, W., SQ, W., L, D., JY, W., & DP., W. (2025). [Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population].. Zhonghua Xue Ye Xue Za Zhi. https://doi.org/10.3760/cma.j.cn121090-20250626-00300
Source records
- europe-pmc · retrieved 2026-09-27T06:28:37.841Z